Dr. William “Pepper” Denman, MBChB, FRCA received his medical training in the United Kingdom, completing his residency at St. Bartholomew’s Hospital in London followed by a fellowship at Massachusetts General Hospital. During his full-time medical practice he was involved in multiple clinical trials and development of pharmaceuticals and devices, particularly in the areas of pediatrics and respiratory devices. Dr. Denman filed and was awarded several patents while focusing on solutions for unmet clinical needs.  Leveraging this expertise, in 2003, he began his career at Tyco Healthcare, now Covidien, becoming the Chief Medical Officer and VP for Medical Affairs in 2007. In 2010, Dr. Denman joined GE Healthcare as Chief Medical Officer, supporting all facets of the business. Following his tenure at GEHC, he set up Denman Associates, where he advised and supported start-up and early stage ventures in the medical device, diagnostics and pharamaceutical space. He is still actively involved in several other early opportunity, while currently serving as the Chief Medical Officer of Sirtex (acquired by a major Chinese pharmaceutical company), a company focused on liver cancer.  Dr. Denman continues to practice at Massachusetts General Hospital in Boston while maintaining his accademic affiliation at Harvard Medical School. He also is co-leader of an annual mission to Vietnam where he provides care to children and medical teaching to those who care for children.